Kimberly K. Adkison
- Virology top 2%
- HIV Research and Treatment 17
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 7
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 7
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 23
- HIV/AIDS Research and Interventions 6
-
- Hepatitis C virus research 8
-
- Liver Disease Diagnosis and Treatment 7
- Pneumocystis jirovecii pneumonia detection and treatment 5
- Co-authors
- Joseph W. PolliCosette J. Serabjit‐SinghStephen A. WringJoan E. HumphreysLindsey O. WebsterChristopher R. GibsonM. Sherry KuVikash K. Sinha
- Cited by
- VirologyPharmacologyOncology
- Journals
- SHILAP Revista de lepidopterología (1 paper)Antimicrobial Agents and Chemotherapy (6 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Kimberly K. Adkison
41 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 101
- Virology 309
- Pharmacology 435
- Oncology 606
- Infectious Diseases 404
- Computational Theory and Mathematics 244
Countries citing papers authored by Kimberly K. Adkison
This map shows the geographic impact of Kimberly K. Adkison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly K. Adkison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly K. Adkison more than expected).
Fields of papers citing papers by Kimberly K. Adkison
This network shows the impact of papers produced by Kimberly K. Adkison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly K. Adkison. The network helps show where Kimberly K. Adkison may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kimberly K. Adkison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 2 | |
| 3 | The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet | 2020 | 1 |
| 4 | 2020 | 3 | |
| 5 | 2019 | 28 | |
| 6 | 2019 | 77 | |
| 7 | 2015 | 2 | |
| 8 | 2013 | 2 | |
| 9 | 2011 | 30 | |
| 10 | 2011 | 104 | |
| 11 | 2011 | 132 | |
| 12 | 2011 | 49 | |
| 13 | 2009 | 36 | |
| 14 | 2008 | 10 | |
| 15 | 2008 | 36 | |
| 16 | 2007 | 13 | |
| 17 | 2006 | 20 | |
| 18 | 2004 | 52 | |
| 19 | 2002 | 458 | |
| 20 | Effects of probenecid on brain-cerebrospinal fluid-blood distribution kinetics of E-Delta 2-valproic acid in rabbits. | 1997 | 11 |
About Kimberly K. Adkison
Kimberly K. Adkison is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 42 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (23 papers), HIV Research and Treatment (17 papers), Hepatitis C virus research (8 papers), Drug Transport and Resistance Mechanisms (7 papers), Liver Disease Diagnosis and Treatment (7 papers), Pharmacogenetics and Drug Metabolism (7 papers), HIV/AIDS Research and Interventions (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). The work is most often cited by research in Virology (309 citations), Pharmacology (435 citations) and Oncology (606 citations). Kimberly K. Adkison has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Joseph W. Polli, Cosette J. Serabjit‐Singh, Stephen A. Wring, Joan E. Humphreys, Lindsey O. Webster, Christopher R. Gibson, M. Sherry Ku, Vikash K. Sinha, Thierry Lavé and Volker Fischer. Their work appears in journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.